WCA
MDT icon

Whetstone Capital Advisors’s Medtronic MDT Stock Holding History

Whetstone Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Buy
2,874
+538
+23% +$51.5K 0.09% 45
2025
Q4 		$224K Sell
2,336
-112
-5% -$10.9K 0.07% 44
2025
Q3 		$233K Buy
+2,448
New +$225K 0.06% 40

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whetstone Capital Advisors's MDT Position: Q1 2026 in Review

Whetstone Capital Advisors increased its Medtronic (MDT) stake by 23% in Q1 2026, buying an estimated $51.5K and bringing the position to 2,874 shares worth $249K. The position accounts for 0.09% of the portfolio, ranked #45.

Whetstone Capital Advisors first reported a position in MDT in Q3 2025 and has held it in 3 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Whetstone Capital Advisors held 2,874 shares of Medtronic worth $249K as of Q1 2026.
  • Whetstone Capital Advisors bought 538 Medtronic shares in Q1 2026, an estimated $51.5K.
  • Medtronic made up 0.09% of Whetstone Capital Advisors's portfolio in Q1 2026, its #45 holding.
  • Whetstone Capital Advisors first reported a position in Medtronic in Q3 2025 and has held it in 3 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Whetstone Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.